Literature DB >> 15907916

alpha-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses.

Robert W Janes1.   

Abstract

alpha-Conotoxins are selective antagonists of neuromuscular or neuronal nicotinic acetylcholine receptors. Individual family members are often highly selective towards distinct receptor subclasses, most notably within neuronal nicotinic acetylcholine receptors. As such they are being used as tools to probe for the type and diversity of receptor subclasses in distinct parts of the central and peripheral nervous systems. Many new alpha-conotoxins are being identified every year, broadening the available armoury because small variations in their sequences and structures often confer altered selectivity towards receptor subunits and subclasses. Many neurological diseases are being associated wholly or in part with functional changes within specific subclasses of nicotinic acetylcholine receptors. Significantly, with more structures of alpha-conotoxins also becoming available this enables ready comparison of their similarities and, more notably, of their subtle differences, which dictate subclass selectivity. As such, alpha-conotoxins offer the potential to become templates for the creation, through rational drug design strategies, of pharmaceuticals highly selective for specific subclasses of nicotinic acetylcholine receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907916     DOI: 10.1016/j.coph.2005.01.013

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  21 in total

1.  Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.

Authors:  Layla Azam; J Michael McIntosh
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

2.  Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.

Authors:  Anton A Grishin; Hartmut Cuny; Andrew Hung; Richard J Clark; Andreas Brust; Kalyana Akondi; Paul F Alewood; David J Craik; David J Adams
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

Review 3.  Cellular events in nicotine addiction.

Authors:  Rachel E Penton; Robin A J Lester
Journal:  Semin Cell Dev Biol       Date:  2009-01-20       Impact factor: 7.727

4.  Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.

Authors:  Todd T Talley; Baldomero M Olivera; Kyou-Hoon Han; Sean B Christensen; Cheryl Dowell; Igor Tsigelny; Kwok-Yiu Ho; Palmer Taylor; J Michael McIntosh
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

Review 5.  NMR and protein structure in drug design: application to cyclotides and conotoxins.

Authors:  Norelle L Daly; K Johan Rosengren; Sónia Troeira Henriques; David J Craik
Journal:  Eur Biophys J       Date:  2011-02-03       Impact factor: 1.733

6.  Synthesis of fluorescent analogs of alpha-conotoxin MII.

Authors:  Vijay A Vishwanath; J Michael McIntosh
Journal:  Bioconjug Chem       Date:  2006 Nov-Dec       Impact factor: 4.774

Review 7.  Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels.

Authors:  David J Adams; Brid Callaghan; Géza Berecki
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 8.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

9.  Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.

Authors:  Michael Ellison; Zhi-Ping Feng; Anthony J Park; Xuecheng Zhang; Baldomero M Olivera; J Michael McIntosh; Raymond S Norton
Journal:  J Mol Biol       Date:  2008-02-04       Impact factor: 5.469

10.  Demonstration of functional alpha4-containing nicotinic receptors in the medial habenula.

Authors:  Carlos Fonck; Raad Nashmi; Ramiro Salas; Chunyi Zhou; Qi Huang; Mariella De Biasi; Robin A J Lester; Henry A Lester
Journal:  Neuropharmacology       Date:  2008-08-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.